Fubao Wang

Consigliere Generale presso PRIME MEDICINE, INC.

Health Technology

Consumer Services

Profilo

Fubao Wang is a Senior VP & Head-Regulatory Affairs at Prime Medicine, Inc. He previously worked as a Director-Regulatory Affairs at Merck & Co., Inc., Vice President & Head-Regulatory at Sarepta Therapeutics, Inc., Associate Vice President at Sanofi, and Senior Vice President & Head-Regulatory Affairs at Asklepios BioPharmaceutical,.
Inc. Wang holds a doctorate from Ruprecht-Karls-Universität Heidelberg and undergraduate and graduate degrees from Nankai University.

Posizioni attive di Fubao Wang

Società	Posizione	Inizio
PRIME MEDICINE, INC.	Consigliere Generale	-

Tutte le posizioni attive di Fubao Wang

Precedenti posizioni note di Fubao Wang

Società	Posizione	Fine
SANOFI	Corporate Officer/Principal	-
SAREPTA THERAPEUTICS, INC.	Consigliere Generale	-
MERCK & CO., INC.	Consigliere Generale	-
Asklepios BioPharmaceutical, Inc. Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC.	Consigliere Generale	-

Vedi nel dettaglio l'esperienza di Fubao Wang

Formazione di Fubao Wang

Ruprecht-Karls-Universität Heidelberg	Doctorate Degree
Nankai University	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Fubao Wang

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	4
PRIME MEDICINE, INC.	Health Technology
SAREPTA THERAPEUTICS, INC.	Health Technology
MERCK & CO., INC.	Health Technology
SANOFI	Health Technology

Aziende private	1
Asklepios BioPharmaceutical, Inc. Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC.	Health Technology

Vedi le connessioni aziendali